Royal Bank of Canada
APGN

Royal Bank of Canada’s Apexigen, Inc. Common Stock APGN Stock Holding History

Royal Bank of Canada’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,750
Closed -$17K – 7792
2021
Q1 		$17K Buy
+1,750
New +$17.5K ﹤0.01% 6537

Other funds holding APGN

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Royal Bank of Canada's APGN Position: Q2 2021 in Review

Royal Bank of Canada sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2021, closing a stake of 1,750 shares — an estimated $17K sold.

Royal Bank of Canada first reported a position in APGN in Q1 2021 and held it in 1 quarter. The position peaked at $17K in Q1 2021. 30 funds tracked by Wall St. Rank hold APGN as of Q2 2021.

  • Royal Bank of Canada reported no remaining Apexigen, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 1,750 Apexigen, Inc. Common Stock shares in Q2 2021, an estimated $17K.
  • Royal Bank of Canada first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Royal Bank of Canada's Apexigen, Inc. Common Stock position peaked at $17K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2021.

Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.